Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions
Author(s) -
Barış Öztürk,
Emin Ediz Tütüncü,
Ferit Kuşçu,
Yunus Gürbüz,
İrfan Şencan,
Hakan Tüzün
Publication year - 2011
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2011.06.005
Subject(s) - medicine , partial thromboplastin time , gastroenterology , crimean–congo hemorrhagic fever , prothrombin time , creatine kinase , myalgia , white blood cell , c reactive protein , fibrinogen , alanine transaminase , lactate dehydrogenase , lymphocytopenia , leukopenia , antithrombin , lymphocyte , immunology , platelet , biochemistry , chemistry , disease , chemotherapy , inflammation , enzyme , heparin
Crimean-Congo hemorrhagic fever (CCHF) is one of the viral hemorrhagic fevers caused by tick bites. Common symptoms of the infection are fatigue, high fever, headache, and myalgia. In some patients hemorrhage may accompany these symptoms and is a sign of a poor prognosis. Typical laboratory changes are thrombocytopenia, leukopenia, elevation of aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine phosphokinase (CPK), and lactate dehydrogenase (LDH), and prolongation of prothrombin time (PT) and activated partial thromboplastin time (aPTT). Mortality rates vary between 3% and 30%. The aim of this study was to determine the factors affecting the prognosis of CCHF.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom